We develop and commercialize medical technologies, specifically targeting chronic disease markets with significant unmet needs. Our growing portfolio of companies covers the areas of cardiology, diabetes, oncology, neurology and rehabilitation. Together, our companies have over 200 scientists, engineers, regulatory and business experts across four continents.
Our foremost duty is to address the needs of the patients and physicians who use our products, ensuring that the products we create are high quality, safe and effective, have a sustained impact on patient health and deliver meaningful cost savings. We undertake to foster a motivating, creative and efficient working environment and to continuously challenge and develop our employees.